Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Oct4-negative multipotent adult progenitor cells and mesenchymal stem cells as regulators of T-cell alloreactivity in mice.

Luyckx A, De Somer L, Jacobs S, Rutgeerts O, Lenaerts C, Roobrouck VD, Verfaillie CM, Waer M, Van Gool SW, Billiau AD.

Immunol Lett. 2011 Jun 30;137(1-2):78-81. doi: 10.1016/j.imlet.2011.02.021. Epub 2011 Mar 4.

PMID:
21382417
2.

Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.

Kovacsovics-Bankowski M, Streeter PR, Mauch KA, Frey MR, Raber A, van't Hof W, Deans R, Maziarz RT.

Cell Immunol. 2009;255(1-2):55-60. doi: 10.1016/j.cellimm.2008.10.004. Epub 2008 Nov 20.

PMID:
19022422
3.

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.

Yañez R, Lamana ML, García-Castro J, Colmenero I, Ramírez M, Bueren JA.

Stem Cells. 2006 Nov;24(11):2582-91. Epub 2006 Jul 27.

4.

Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.

Tian Y, Deng YB, Huang YJ, Wang Y.

Immunol Invest. 2008;37(1):29-42. doi: 10.1080/08820130701410223.

PMID:
18214798
5.

The immunosuppressive effect of embryonic stem cells and mesenchymal stem cells on both primary and secondary alloimmune responses.

Han KH, Kang HG, Gil HJ, Lee EM, Ahn C, Yang J.

Transpl Immunol. 2010 Jul;23(3):141-6. doi: 10.1016/j.trim.2010.04.006. Epub 2010 Apr 27.

PMID:
20430098
6.

IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.

Kaneko S, Mastaglio S, Bondanza A, Ponzoni M, Sanvito F, Aldrighetti L, Radrizzani M, La Seta-Catamancio S, Provasi E, Mondino A, Nagasawa T, Fleischhauer K, Russo V, Traversari C, Ciceri F, Bordignon C, Bonini C.

Blood. 2009 Jan 29;113(5):1006-15. doi: 10.1182/blood-2008-05-156059. Epub 2008 Oct 31.

PMID:
18978209
7.

Multipotent Adult Progenitor Cells Suppress T Cell Activation in In Vivo Models of Homeostatic Proliferation in a Prostaglandin E2-Dependent Manner.

Carty F, Corbett JM, Cunha JPMCM, Reading JL, Tree TIM, Ting AE, Stubblefield SR, English K.

Front Immunol. 2018 Apr 23;9:645. doi: 10.3389/fimmu.2018.00645. eCollection 2018.

8.

Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.

Xu G, Zhang L, Ren G, Yuan Z, Zhang Y, Zhao RC, Shi Y.

Cell Res. 2007 Mar;17(3):240-8.

9.

Human multipotent adult progenitor cells are nonimmunogenic and exert potent immunomodulatory effects on alloreactive T-cell responses.

Jacobs SA, Pinxteren J, Roobrouck VD, Luyckx A, van't Hof W, Deans R, Verfaillie CM, Waer M, Billiau AD, Van Gool SW.

Cell Transplant. 2013;22(10):1915-28. doi: 10.3727/096368912X657369. Epub 2012 Oct 1.

PMID:
23031260
10.

Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.

Pachnio A, Dietrich S, Klapper W, Humpe A, Schwake M, Sedlacek R, Gramatzki M, Beck C.

Bone Marrow Transplant. 2006 Jul;38(2):157-67.

PMID:
16820783
12.

Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.

Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koç ON.

Bone Marrow Transplant. 2004 Mar;33(6):597-604.

PMID:
14716336
13.

The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.

Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F.

Cell Immunol. 2008 Feb;251(2):131-6. doi: 10.1016/j.cellimm.2008.04.009. Epub 2008 May 27.

PMID:
18502411
14.

Transplanted mesenchymal stem cells can inhibit the three developmental stages of murine acute graft-versus-host disease.

Li H, Guo Z, Zhu H, Li XS, Jiang X, Yao H, Wang X, Liao L, Liu Y, Wu Y, Zhang Y, Mao N.

In Vivo. 2010 Sep-Oct;24(5):659-66.

PMID:
20952730
16.

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.

Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.

Transplantation. 2007 Jul 27;84(2):231-7.

PMID:
17667815
17.

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.

Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ.

Blood. 2004 Feb 15;103(4):1534-41. Epub 2003 Oct 9.

PMID:
14551132
18.

Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.

Maccario R, Podestà M, Moretta A, Cometa A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, Frassoni F, Locatelli F.

Haematologica. 2005 Apr;90(4):516-25.

19.

Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.

Lu X, Liu T, Gu L, Huang C, Zhu H, Meng W, Xi Y, Li S, Liu Y.

Transpl Immunol. 2009 Dec;22(1-2):55-61. doi: 10.1016/j.trim.2009.08.002. Epub 2009 Aug 18.

PMID:
19695330
20.

Supplemental Content

Support Center